Ananthan Sadagopan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Ananthan Sadagopan

Aug 24, 2024, 06:53 | Insight

Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma

Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…

Jul 31, 2024, 11:17 | Insight

Gunsagar Gulati: Two extraordinary papers released on BioRxiv

Gunsagar Gulati, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X about two…

Jul 31, 2024, 07:46 | Blog

William Gibson: Molecular glues that finally 'drug' TP53

Michael Gibson, Executive Board Member at EXCITE International, shared a post by William Gibson, Medical Oncologist…

Jul 31, 2024, 00:54 | Blog

Toni Choueiri: One of the coolest things I have seen recently

Toni Choueiri shared a post by William Gibson, Medical Oncologist at Dana-Farber Cancer Institute, on X,…

Jul 30, 2024, 13:03 | Insight

William Gibson: A general strategy for TP53 missense mutant cancers with prototype small molecules

Harold J. Burstein, Breast cancer specialist and professor at Dana Farber Cancer Institute, shared a…

All: 5 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023